Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients. The gene discussed is SPARC; the disease is metabolic dysfunction-associated steatotic liver disease.